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Edited by Jesus AvilaAbstract We have studied how prion infection may aﬀect the
Src kinase activity in three diﬀerent neuronal cell lines, ScGT1
and ScN2a, where ScGT1 were generated in our laboratory.
By immunoblotting, using clone 28 – a monoclonal antibody rec-
ognizing active Src, we have found a 32 ± 6.3% and 75 ± 7.7%
elevation in Src activity in ScGT1 and ScN2a cells, respectively,
compared to uninfected cells. Immunocomplex in vitro kinase as-
say conﬁrmed the increased Src activity. The increased Src ki-
nase activity in scrapie-infected cells was further shown to
correlate to an increased level of Src protein.
In addition, an important increase in the protein tyrosine phos-
phorylation signal was observed in ScGT1 and ScN2a cells,
which was further shown to be Src-dependent, as treatment with
PP2 – a Src family kinase speciﬁc inhibitor, reversed the protein
tyrosine phosphorylation proﬁle. Abnormal Src-kinase activa-
tion and subsequent protein tyrosine phosphorylation may be
key elements in the neuropathology of the prion diseases.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The cellular prion protein (PrPC) is a ubiquitous glycopro-
tein, mainly expressed in neurons. In prion diseases PrPC is
converted into an abnormal conformer, designated pathogenic
scrapie isoform of PrPC (PrPSc), enriched in b-sheets and resis-
tant to proteinase K (PK) digestion [1]. PrPC is a glycosylphos-
phatidylinositol (GPI)-anchored protein, predominantly
distributed in synapses [2] and localized to sphingolipid- and
cholesterol-rich membrane domains also called lipid rafts [3].
Lipid rafts are highly specialized microdomains, functioning
as platforms for the attachment of lipid-modiﬁed proteins
e.g. GPI-anchored proteins, receptor tyrosine kinases (RTKs)
and Src-family tyrosine kinases. Lipid rafts and early endo-
somes are also suggested to be the site of conversion of PrPC
to PrPSc [4].Abbreviations: CNS, central nervous system; GPI, glycosylphosphat-
idylinositol; IP, immunoprecipitate; mAb, monoclonal antibody; PBS,
phosphate buﬀered saline; PK, proteinase K; PP2, 4-Amino-5-(4-chl-
orophenyl)-7-(t-butyl)pyrazolo(19)pyrimidine; PrPC, cellular prion
protein; PrPSc, pathogenic scrapie isoform of PrPC; pTyr, phospho-
tyrosine; RTKs, receptor tyrosine kinases; SDS–PAGE, sodium dod-
ecyl sulphate–polyacrylamide gel electrophoresis
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doi:10.1016/j.febslet.2006.03.092Although the physiological function of PrPC still remains
unclear, several plausible roles of PrPC have emerged. One sug-
gests that PrPC protects against oxidative stress, possibly
through the regulation of synaptic copper transport [5].
Another imply PrPC as a cell-surface receptor, mediating neu-
ronal survival [6] and neurite outgrowth, as shown by laminin-
induced neuritogenesis of primary neurons from wild-type but
not PrP null mice [7]. Consistent with a role of PrPC as a sig-
naling molecule is the ﬁnding that (I) PrPC co-localizes with
and co-immunoprecipitates Src-family kinases [8] and (II) anti-
body-mediated ligation of PrPC promotes dephosphorylation
and activation of Src-family kinases in various cell types
[9,10]. In mice devoid of PrPC, long-term potentiation is im-
paired, indicating a synaptic function of PrPC [11]. Synaptic
degeneration is one of the earliest neuropathological features
in prion diseases [12].
Src is the prototype member of a family of non-receptor pro-
tein tyrosine kinases with nine members, ﬁve of which Src,
Fyn, Lyn, Lck and Yes are expressed in the central nervous
system (CNS). Within CNS neurons, Src is found both pre-
and post-synaptically [13]. Src-family kinases control diverse
cellular functions such as cell proliferation, diﬀerentiation
and apoptosis [14]. In the adult nervous system, Src kinases
are implicated in ion channel activity and synaptic plasticity,
as well as in neurodegeneration [15].
Given that PrPC both colocalizes with and may activate
Src-family kinases, we hypothesized that the formation and
accumulation of PrPSc in raft-domains may induce an
uncontrolled activation of Src-kinases, possibly responsible
for the synaptic degeneration in prion diseases. This study
therefore sought to identify how prion-infection may aﬀect
the activity of the Src-kinase as well as its downstream sig-
naling targets.2. Materials and methods
2.1. Materials
Anti-PrP (sc-7694) and N-16 (sc-19) antibodies were purchased
from Santa Cruz Biotechnology Inc. HRP-conjugated sheep-anti-
mouse and protein-G sepharose beads (4FF) were from Amersham-
Biosciences. Anti-phosphotyrosine (anti-pTyr) antibody (4G10) was
from Upstate Biotechnology Inc. Clone 28 antibody [16] was kindly
provided by Prof. Koji Owada at Kyoto Pharmaceutical University,
Japan. Mouse monoclonal pp60Src antibody (clone 327) [17] was a
kind gift of Prof. Joan Brugge, Harvard Medical School, USA. 4-
Amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo(19)pyrimidine (PP2)
was purchased from Calbiochem. [c-32P]ATP, 10 Ci/mmol was from
Perkin–Elmer Life and Analytical Sciences, Boston, MA. All cell
culture reagents were from Invitrogen, Stockholm, Sweden. All other
reagents were from Sigma.blished by Elsevier B.V. All rights reserved.
2604 H. Gyllberg et al. / FEBS Letters 580 (2006) 2603–26082.2. Generation of ScGT1 cells
Brain homogenate from Rocky Mountain Laboratories (RML)
prion-infected CD-1 mice was kindly provided by Prof. Stanley B.
Prusiner at UCSF, CA. ScGT1a and ScGT1b cells were generated
at two diﬀerent occasions by inoculating GT1-1 [18] cells (immortal-
ized murine hypothalamic neuronal cell line) with RML brain
homogenate as described in [19]. ScN2a cells were together with
the non-infected murine neuroblastoma cell line N2a generously pro-
vided by Stanley B. Prusiner. N2a cells were also purchased from
ATCC.Fig. 1. Detection of PK-resistant PrPSc in ScN2a and ScGT1a/b cells.
Non-treated () and PK-treated (+) cell lysates of N2a, ScN2a, GT1
and ScGT1a/b were loaded on 12% polyacrylamide gel, transferred to
nitrocellulose membrane and PrP isoforms were detected by the
speciﬁc anti-PrP antibody. 90% of each cell lysate (0.45 mg) was PK-2.3. Cell culture and detection of PrPSc
All cells were routinely cultured at 37 C under an atmosphere of 5%
CO2 in DMEM with Glutamax II and 4.5 g/l D-glucose supplemented
with penicillin–streptomycin and 5% fetal bovine serum (N2a/ScN2a)
or 5% fetal bovine serum and 5% horse serum (GT1/ScGT1a/b).
ScN2a, ScGT1a and ScGT1b were regularly controlled for scrapie
infection by detection of PrPSc, as described in [19].treated with 20 lg PK/mg protein for 1 h at 37 C. Remaining 10% of
the cell lysate was undigested.2.4. PP2 treatment
2 · 106 GT1/ScGT1b cells or 5 · 105 N2a/ScN2a cells were seeded in
6 cm culture dishes three days before treatment for 24 h in the presence
or absence of 1 lM PP2 for N2a/ScN2a or 3 lM PP2 for GT1/ScGT1.
A lower concentration of PP2 (1 lM) was used for N2a/ScN2a cells
because 3 lM PP2 was lethal to the N2a cells. After treatment, cell
lysates were subjected to anti-pTyr immunoprecipitation and/or anti-
pTyr immunoblotting. Western blot and immunoprecipitation were
performed as described in [20].2.5. In vitro Src kinase assay
1 mg of protein from the indicated cell lysates was
immunoprecipitated with the Src-antibody (N-16). Following immu-
noprecipitation the protein-G sepharose beads were washed three
times with kinase buﬀer (50 mM HEPES, 10 mM MgCl2, and
1 mM MnCl2). The in vitro kinase reaction was carried out in
20 ll kinase buﬀer containing 3 lM unlabeled ATP, 3 lCi of
[c-32P]ATP, 10 lg of the exogenous Src kinase substrate muscle rab-
bit enolase (Sigma E0379). The enolase was pretreated in 25 lM
acetic acid for 10 min at 30 C. Samples were incubated for
30 min, 30 C and stopped by the addition of 10 ll of 4· Laemmli
sample buﬀer and boiled for 5 min. 10 ll of the reaction mix was
separated by 10% sodium dodecyl sulphate–polyacrylamide gel
electrophoresis (SDS–PAGE). The gel was dried and exposed to a
X-ray ﬁlm for 18 h. Densitometric measurements of the autoradio-
graphic results was performed on a PC using the program Image
Gauge, v. 3.46.3. Results
3.1. Generation of scrapie-infected GT1 cells (ScGT1a and
ScGT1b)
In addition to ScN2a cells, two scrapie-infected GT1 cell
lines (ScGT1a and ScGT1b) were generated by inoculating
the highly diﬀerentiated hypothalamic GT1 cell line with
RML-brain homogenate, with the aim to obtain several
prion-infected cell lines. The presence of PrPSc was analyzed
after six passages (2 months) by immunoblotting of PK-trea-
ted cell lysates with a PrP speciﬁc antibody. PK-resistant
PrPSc was detected in ScN2a, ScGT1a and ScGT1b, but
not in uninfected N2a and GT1 cells (Fig. 1). ScGT1b cells
showed a 3-fold increased level of PK-resistant PrPSc
compared to ScGT1a. At present we cannot distinguish if
a larger proportion of cells in the ScGT1b population is in-
fected (i.e. produce PrPSc) or if certain individual cells in
ScGT1b produce an increased amount of PrPSc, which on
a Western blot of PK-treated cell lysate would give the same
result.3.2. Increased levels of active Src kinase in scrapie-infected cells
The level of active Src was determined by Western blot of
immunoprecipitated Src with monoclonal antibody (mAb)
clone 327 and further blotted with mAb, clone 28 (recogniz-
ing active Src), Fig. 2A. Densitometric measurements
revealed a 32 ± 6.3% (P = 0.0418, n = 3) increase in clone
28-immunoreactivity in ScGT1b compared to GT1 cells
(Fig. 2A) when the same amount of protein was loaded. A
signiﬁcant increase was also observed in ScN2a, i.e.
75 ± 7.7% (P = 0.0168, n = 3) increase compared to unin-
fected controls (Fig. 2A). The blots in Fig. 2A were dehy-
bridized and rehybridized with the Src antibody clone 327
in order to determine the protein level of Src (Fig. 2B).
Comparing the amount of active Src (clone 28-immunoreac-
tivity, Fig. 2A) captured in the clone 327-IP, to the amount
of total Src in the same lanes (clone 327-immunoreactivity,
Fig. 2B), no increase in the speciﬁc activity of Src was ob-
served. A similar increase in Src protein level (25%) was also
found in the independently prion-infected ScGT1a (Fig. 2D),
strongly indicating that increased Src protein level is a result
of scrapie infection and not a clonal eﬀect, as an increased
amount of Src can be shown in several RML-infected neu-
ronal cell lines.3.3. Increased tyrosine phosphorylation in scrapie-infected cells
To determine whether the increased levels of active Src in
scrapie-infected cells could inﬂuence the overall protein tyro-
sine phosphorylation of cellular proteins, anti-pTyr staining
of whole cell lysates was performed. As shown in Fig. 3A, a
major change in pTyr proﬁle was observed between GT1 and
ScGT1b, with an increased phosphorylation of several high
molecular weight protein bands of 70–180 kDa in ScGT1b
(Fig. 3A). Similar changes were also observed comparing
N2a and ScN2a cells, with both the magnitude and the number
of tyrosine phosphorylated proteins increased compared to
N2a. In both ScGT1b and ScN2a cells the majority of proteins
with increased tyrosine phosphorylation is phosphorylated
also in the native cells, although to a much lesser extent. Still,
two proteins (pp97 and pp180) only appeared in ScN2a,
indicating also novel targets for the increased tyrosine phos-
phorylation in ScN2a. The overall tyrosine phosphorylation
in ScGT1b and ScN2a were 71 ± 8.1% (P = 0.032, n = 3) and
Fig. 2. Increased levels of active Src protein levels in scrapie-infected
cells. (A) Anti-Src immunoprecipitates (clone 327-IPs), from 1 mg of
protein from the indicated cell types were immunoblotted with clone
28. (B) The blots were dehybridized and rehybridized with clone 327.
(C) Densitometric measurements of (A) and (B), respectively. (D) Anti-
Src immunoprecipitates (clone 327-IPs) from 1 mg of protein from
GT1 and ScGT1a were immunoblotted with clone 28 (upper panel).
The membrane was dehybridized and rehybridized with clone 327.
IP = immunoprecipitated, IB = immunoblotted, cl 327 = clone 327,
* = P < 0.05, Student’s t-test, n = 3.
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N2a, respectively, as assessed by densitometry.
A higher resolution of the scrapie-induced increase of phos-
phorylated proteins was obtained by pTyr-staining of anti-
pTyr immunoprecipitates from uninfected and infected cells
(Fig. 3B). Three major bands with an increased tyrosine phos-
phorylation were detected in ScGT1b and ScN2a, although of
diﬀerent molecular weights, possibly with the exception of the
pp116 protein. All of them were mainly or completely absent
in immunoprecipitates from GT1 and N2a, respectively. Den-
sitometric measurements showed a 4-fold enrichment in tyro-
sine phosphorylated proteins in ScGT1b (4.13 ± 0.4,
P = 0.002, n = 3) and ScN2a (4.4 ± 0.5, P = 0.006, n = 3),
respectively, compared to uninfected cells. A similar increase
in tyrosine phosphorylation was conﬁrmed in ScGT1a
(Fig. 3C), showing a 39% increase in the pTyr-staining ofwhole cell lysate compared to GT1 cells. Fig. 3C, right panel,
shows a 2.6-fold increase in the pTyr-staining of anti-pTyr-
immunoprecipitates.
A possible explanation for the diﬀerent sets of tyrosine phos-
phorylated proteins in ScGT1 compared to ScN2a, could be
their diﬀerent neuronal origins. The N2a cells are derived from
a spontaneous neuroblastoma arising in A/J mice [21] whereas
the GT1 cells originate from hypothalamic neurons, immortal-
ized by genetically targeted tumorigenesis in transgenic mice
[22]. Correspondingly, the enhanced cellular response (i.e. in-
creased Src kinase level and protein tyrosine phosphorylation)
in ScN2a compared to ScGT1 cells, despite the lower amount
of PrPSc in ScN2a compared to ScGT1a/b could also be due to
their diﬀerent neuronal origins. However and interestingly,
within the same cell type (ScGT1a/b), there is an apparent po-
sitive correlation between the amount of PrPSc and the degree
of increased Src kinase level and tyrosine phosphorylation of
cellular proteins (Figs. 1–3).3.4. Elevated tyrosine phosphorylation in scrapie-infected cells is
inhibited with the selective Src kinase inhibitor, PP2
pTyr staining of whole cell lysates and anti-pTyr immuno-
precipitates were assessed after treatment of GT1/ScGT1b
and N2a/ScN2a with the Src speciﬁc inhibitor PP2 for 24 h.
In ScGT1b, PP2 treatment for 24 h reversed the protein tyro-
sine phosphorylation to the same basal level as in GT1, clearly
demonstrating that the increased tyrosine phosphorylation in
ScGT1b is due to increased Src kinase activity (Fig. 4A/B, left
panels). A signiﬁcant decrease in protein tyrosine phosphoryla-
tion was also observed in ScN2a after a 24 h-treatment with
PP2 (Fig. 4A/B, right panels), although not to the same degree
as in ScGT1b. This suggests that also other protein tyrosine ki-
nases e.g. the Abl or focal adhesion kinase (FAK) families, not
inhibited by PP2, are upregulated in ScN2a cells. ScN2a cells
were also treated with 3 lM PP2 for 24 h, however no further
decrease in protein tyrosine phosphorylation was observed
compared to ScN2a treated with 1 lM PP2 (data not shown).3.5. Increased in vitro Src kinase activity in scrapie-infected
cells – inhibited by PP2
To verify the increased Src kinase activity in ScGT1b and
ScN2a as detected by clone 28-immunoreactivity, an in vitro
kinase assay was performed using Src-immunoprecipitates.
The N-16 antibody was used to immunoprecipitate Src, as
binding of Src to the other available antibody may per se stim-
ulate Src activity as reviewed in [23]. Densitometric measure-
ments of the autoradiography of [32P]-labeled Src substrate,
enolase, showed a 71 ± 2.3% and a 72 ± 4.0% increased kinase
activity in ScGT1b and ScN2a, respectively, compared to unin-
fected controls (Fig. 5). Addition of PP2 to the in vitro kinase
reaction mix completely inhibited phosphorylation of enolase,
again conﬁrming the involvement of increased Src kinase activ-
ity in ScGT1b and ScN2a. The clone 28-immunoreactivity of
N-16-IPs shows a 35 ± 5.3% and a 68 ± 7.5% increase in
ScGT1b and ScN2a, respectively, compared to non-infected
cells (data not shown). This increase corresponds to the in-
crease in total Src kinase protein levels (clone 327-immunore-
activity of the same N-16-IPs) in both scrapie-infected cell
lines compared to non-infected. The higher increase in Src ki-
nase activity in ScGT1b observed by the in vitro kinase assay
compared to the increase observed with clone 28 staining may
Fig. 3. Increased protein tyrosine phosphorylation in scrapie-infected cells. (A) Anti-pTyr staining of whole cell lysates of GT1, ScGT1b, N2a and
ScN2a (20 lg protein/lane). Ponceau staining of the blot conﬁrms equal amount of loaded proteins. Diagram beneath shows densitometric analysis of
anti-pTyr staining. (B) 1 mg of protein from GT1, ScGT1b, N2a and ScN2a was immunoprecipitated with anti-pTyr antibody and immunoblotted
with the same antibody. IgG-staining is indicated and serves to conﬁrm equal amount of added antibody. The diagram shows densitometric analysis
of the anti-pTyr staining, * = P < 0.05, ** = P < 0.01, Student’s t-test, n = 3. (C) pTyr-staining of whole cell lysate (20 lg protein) from GT1 and
ScGT1a (left panel) and pTyr staining of 1 mg of proteins from GT1 and ScGT1a immunoprecipitated with anti-pTyr antibody (right panel).
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between phospho-Y416 (active) and Y416 (less active),
whereas the phospho-Y416 Src is mainly detected by the
in vitro kinase assay. This suggests that the ratio of phos-
pho-Y416 in ScGT1b and GT1 is larger than 1.4. Discussion
This report shows, in three independently prion-infected cell
lines: ScN2a, ScGT1a and ScGT1b – a signiﬁcant increase in
active Src-kinase protein levels. A similar ﬁnding was recently
reported by R. Nixon, showing an elevation of Src-family ki-
nases in scrapie-infected brains and in ScN2a [24]. We also
show, for the ﬁrst time, that the increased Src-kinase protein
levels in ScGT1a/b and ScN2a cells is associated with a signif-
icant elevation in protein tyrosine phosphorylation, which was
eﬃciently blunted in the presence of the Src-kinase inhibitor
PP2.
While considerable knowledge has accumulated on the regu-
lation of Src kinase activity, virtually nothing is known about
the transcriptional regulation of this kinase. However, besidesa transcriptional and/or translational regulation, recent evi-
dence suggests that Src-kinases are subject to a ubiquitin-
dependent degradation, involving the Src-substrate c-Cbl E3
ubiquitin ligase [25,26]. Ubiquitin-dependent proteolysis is also
responsible for the elimination of misfolded proteins, including
PrPSc in prion-infected neurons [27], and in scrapie-infected
mouse brains the level of ubiquitinated proteins was signiﬁ-
cantly increased, concurrent with a decline in the proteasomal
endopeptidase activity [28]. This suggests that the accumula-
tion of PrPSc in infected cells overwhelms the ubiquitin-protea-
some system and therefore, if this system is deregulated in
scrapie-infected cells, the result may well be elevated levels of
activated Src. Further studies are required to establish why
the steady state level of Src is increased in scrapie-infected
cells.
The important changes in protein tyrosine phosphoryla-
tion observed in ScGT1a/b and ScN2a cells certainly have
important consequences on cell signalling, synaptic function
and viability. Interestingly, tau and several other neuronal
proteins were shown to be tyrosine phosphorylated in re-
sponse to the amyloid b peptide in a Src-dependent manner
[29].
Fig. 5. In vitro Src kinase assay. The exogenous Src kinase speciﬁc
substrate enolase was incubated with immunoprecipitated Src kinase
(using N-16) and [c-32P]ATP in a reaction buﬀer, 30 min at 30 C, and
thereafter separated by 10% SDS–PAGE. The in vitro Src kinase assay
was performed in the absence or presence of 10 lM PP2, which was
added 30 min before [c-32P]ATP. The gel was dried and exposed to a
X-ray ﬁlm for 18 h. Autoradiography revealed phosphorylated enolase
at 47 kDa. Densitometric analysis was performed on a PC using the
program Image Gauge, v. 3.46. The control contained the same
reaction components except immunoprecipitated Src kinase.
Fig. 4. The Src-kinase speciﬁc inhibitor PP2 eﬀectively inhibits scrapie-induced protein tyrosine phosphorylation. (A) Anti-pTyr staining of whole
cell lysates (20 lg protein/lane) of GT1, ScGT1b, N2a and ScN2a untreated or treated with 1 or 3 lM PP2 for 24 h. (B) Cells were untreated or
treated with 1 or 3 lM PP2 for 24 h, as indicated. 1 mg of cellular proteins was immunoprecipitated with anti-pTyr antibody and immunoblotted
with anti-pTyr antibody. IgG-staining conﬁrms equal amount of added antibody.
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phosphorylation was eﬃciently reversed by a Src-kinase inhib-
itor – completely in ScGT1b cells, whereas only partly in
ScN2a. This suggests that also other Src-independent tyrosine
kinase activities are upregulated in ScN2a cells. Of note, the
tyrosine kinase inhibitor STI571 induces cellular clearance of
PrPSc in prion-infected cells by activation of lysosomal degra-
dation of PrPSc [30]. Thus, a possible scenario is that PrPSc in-
duces an increased tyrosine kinase activity, which slow down
cellular clearance of PrPSc and thereby facilitates PrPSc replica-
tion.
In conclusion, the upregulated Src-kinase activity and conse-
quent increase in protein tyrosine phosphorylation in prion-in-fected neurons may cause or contribute to synaptic
disorganization and loss, which is a fundamental and constant
feature of prion diseases.
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